Strategic investment and collaboration provide new parents with easy-to-access innovative screening option to positively impact the earliest stages of the Duchenne care continuum NEWPORT BEACH, Calif.–(BUSINESS WIRE) – CureDuchenne, the […]
NEWPORT BEACH, Calif. – (BUSINESS WIRE) – CureDuchenne, a national venture philanthropy nonprofit focused on finding a cure for Duchenne muscular dystrophy (DMD), announced today a $500,000 investment into 4D […]
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–The DuchenneXchange.org has a reason to celebrate on World Duchenne Day. The dedicated online platform for the Duchenne muscular dystrophy (DMD) community announced today it has surpassed enrollment goals […]
Dear Friends, Today, our partner Dr. Eric Olson and his team at Exonics, a company CureDuchenne helped form, published data in the online journal, Science that shows an increase in […]
NEWPORT BEACH, CALIFORNIA, AUGUST 17, 2018 – CureDuchenne, a leading nonprofit focused on funding research to find a cure for Duchenne muscular dystrophy, is thrilled and honored to announce that […]
DuchenneXchange, the dedicated online platform built by the Duchenne community for the Duchenne community, will host a free hour-long webinar for Duchenne community members to learn about the benefits of […]
Dedicated Online Platform DuchenneXchange.org Launches to Unite, Support and Educate Duchenne Community Collaborative site offers a trustworthy, moderated online space where Duchenne families, caregivers, NGOs and pharmaceutical companies can connect […]
PTC Therapeutics Update on Ataluren Study 041 PTC Therapeutics is enrolling boys and young men with a nonsense mutation in a clinical trial for Ataluren. To ensure that participants who […]
The third day of the conference focused on stem cells, new small molecule screens, poster sessions and clinical trial updates. Hirofumi Komaki (National Center of Neurology and Psychiatry, Japan) presented […]
